Osiris Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Osiris Therapeutics ( OSIR) is a stem cell therapeutic company. Osiris Therapeutics is focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. This stock is trading up 4.5% at $10.98 in recent trading.

Today's Volume: 584,000

Average Volume: 418,413

Volume % Change: 90%

From a technical perspective, OSIR is ripping to the upside here off some near-term support at $10 with above-average volume. This move is coming after the stock pulled back from its recent high of $14.46.

>>5 Stocks Under $10 Set to Soar

Traders should now look for long-biased trades if OSIR can manage to trigger a near-term breakout trade. That trade will hit once OSIR takes out some overhead resistance at $11.18 with high-volume. Look for a sustained move or close above $11.18 with volume that's near or above 418,413 shares. If we get that action soon, then OSIR could make a quick move toward $13 to $14.

On the flipside, I would avoid OSIR or look for short-biased trades if the stock fails to trigger that breakout, and then moves back below support at $10 with high-volume.

If you liked this article you might like

Stocks Under $10 Portfolio: Not Resting on Our Laurels

How to Cash in on the Fight Against the Zika Virus

OraSure (OSUR) Stock Spikes, Upgraded at Stephens

4 Stocks for Fighting Zika

OraSure Technologies (OSUR) Stock Jumps on Zika Test Contract